1 July 2002 in Fitoterapia
1 July 2000 in Current Pharmaceutical Design
The influence of drugs on the labeling of red blood cells and plasma proteins with 99mTc has been reported. Any drug, which alters the labeling of the tracer, could be expected to modify the disposition of the radiopharmaceuticals. Red blood cells (RBC) labeled with technetium-99m (99mTc) are used for several evaluations in nuclear medicine. We have evaluated the effect of Thuya occidentalis, Peumus boldus and Nicotiana tabacum (tobacco) extracts on the labeling of RBC and plasma and cellular proteins with 99mTc. Blood was incubated with the drugs. Stannous chloride (SnCl2) solutions and 99mTc were added. Plasma (P) and blood cells (BC) were separated. The percentage of radioactivity (%ATI) bound to P and BC was determined. The %ATI on the plasma and cellular proteins was also evaluated by precipitation of P and BC samples with trichloroacetic acid (TCA) and isolation of soluble (SF) and insoluble (IF) fractions. The analysis of the results shows that there is a decrease in %ATI (from 97.64 to 75.89 percent) in BC with Thuya occidentalis extract. The labeling of RBC and plasma proteins can be decreased in presence of tobacco. This can be due either a direct or indirect effect (reactive oxygen species) of tobacco. The analysis of radioactivity in samples of P and BC isolated from samples of whole blood treated with Peumus boldus showed a rapid uptake of the radioactivity by blood cells in the presence of the Peumus boldus, whereas there was a slight decrease in the amount of 99mTc radioactivity in the TCA-insoluble fraction of plasma. This study shows that extracts of some medicinal plants can affect the radiolabeling of red blood cells with 99mTc using an in vitro technique.
1 September 2000 in Journal of Ethnopharmacology
JOJoelma Fonseca de Oliveira
Joelma Fonseca de Oliveira
MOMárcia B Nunes de Oliveira
Márcia B Nunes de Oliveira
ACAdriano Caldeira-De-Araújo
Adriano Caldeira-De-Araújo
+2
1 January 2003 in Food and Chemical Toxicology
MCM.T Jansen de Almeida Catanho
M.T Jansen de Almeida Catanho
+2
22 January 2002 in Journal of Applied Toxicology
DMDeise Mara Machado de Mattos
Deise Mara Machado de Mattos
RFRosimeire de Souza Freitas
Rosimeire de Souza Freitas
RBRoberto José A.C. Bezerra
Roberto José A.C. Bezerra
+1
29 January 2012 in African Journal of Pharmacy and Pharmacology
Baccharis trimera (carqueja) has been used in folk medicine to treat rheumatism, diabetes and digestive disorders, and suggested as anti-inflammatory, analgesic, anti-ulcerative and antihepatotoxic. Blood constituents have been labeled with technetium-99m (99mTc) and used in nuclear medicine. The influence of natural and synthetic drugs in this procedure has been reported. In this work, the influence of an aqueous carqueja extract on the labeling of blood constituents with 99mTc and morphology of red blood cells was evaluated. Blood samples of Wistar rats were incubated with different concentrations of carqueja extract. The labeled process with 99mTc was the performed. Blood cells (BC) and plasma (P) were isolated. Aliquots of BC and P were precipitated and soluble (SF) and insoluble (IF) fractions separated. The radioactivity in each fraction was counted and percentage of incorporated radioactivity (%ATI) determined. Blood smears were performed for morphological evaluation. The data show a significant (P < 0.05) alteration of %ATI in BC and IF-P as well as morphology of red blood cells from blood incubated with carqueja extract. The results suggest that aqueous carqueja extract could presents an antioxidant action and/or alters the membrane structures involved in ions transport into cells decreasing the radiolabeling of blood constituents with 99mTc. Key words: Baccharis trimera, blood constituents, radiolabeling, technetium-99m, stannous ion.